Anti-BDBV Matrix Protein VP40 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22247; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-BDBV Matrix Protein VP40 Polyclonal Antibody – the ultimate solution for your biotech research needs. This highly specific antibody is designed to target the matrix protein VP40 of the deadly Bundibugyo virus (BDBV), making it an essential tool for studying and understanding this viral pathogen.
The biological function of this antibody lies in its ability to bind to the VP40 protein, which plays a crucial role in the assembly and release of BDBV particles. By targeting this protein, our antibody enables researchers to study the virus’s life cycle and mechanisms of infection, ultimately leading to a better understanding of its pathogenicity.
The main applications of our Anti-BDBV Matrix Protein VP40 Polyclonal Antibody include immunofluorescence, immunohistochemistry, and Western blotting. These techniques allow for the visualization and detection of VP40 in infected cells or tissues, providing valuable insights into the virus’s behavior and interactions with host cells.
In addition, this antibody has been extensively validated for use in various experimental conditions, ensuring reliable and reproducible results. It has been tested in multiple cell lines, including human and primate cell lines, as well as in animal models, making it a versatile and reliable tool for a wide range of research studies.
Our Anti-BDBV Matrix Protein VP40 Polyclonal Antibody is a crucial asset for researchers studying BDBV and other related viruses. Its high specificity and sensitivity make it an ideal choice for investigating the molecular mechanisms of viral infection and developing potential treatments.
Don’t miss out on this essential tool for your biotech research. Order our Anti-BDBV Matrix Protein VP40 Polyclonal Antibody now and take your studies to the next level.
ProteoGenix catalogue number ARO-A22247. For research use only.
Target: VP40, VP40; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| VP40, VP40 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
